Singapore markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
372.04-5.29 (-1.40%)
At close: 04:00PM EDT
372.04 0.00 (0.00%)
After hours: 05:41PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 27.24B
Enterprise value 26.69B
Trailing P/E 47.21
Forward P/E 48.78
PEG ratio (5-yr expected) 6.58
Price/sales (ttm)9.50
Price/book (mrq)9.45
Enterprise value/revenue 9.05
Enterprise value/EBITDA 31.61

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 30.02%
S&P500 52-week change 320.07%
52-week high 3415.73
52-week low 3310.42
50-day moving average 3379.82
200-day moving average 3371.23

Share statistics

Avg vol (3-month) 3527.81k
Avg vol (10-day) 3341.91k
Shares outstanding 573.21M
Implied shares outstanding 673.44M
Float 872.82M
% held by insiders 10.56%
% held by institutions 195.84%
Shares short (28 Mar 2024) 41.13M
Short ratio (28 Mar 2024) 42.3
Short % of float (28 Mar 2024) 42.02%
Short % of shares outstanding (28 Mar 2024) 41.55%
Shares short (prior month 29 Feb 2024) 41.2M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.22%
Trailing annual dividend rate 30.77
Trailing annual dividend yield 30.20%
5-year average dividend yield 40.26
Payout ratio 49.77%
Dividend date 301 May 2024
Ex-dividend date 423 Apr 2024
Last split factor 22:1
Last split date 327 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 20.12%
Operating margin (ttm)23.63%

Management effectiveness

Return on assets (ttm)11.93%
Return on equity (ttm)21.32%

Income statement

Revenue (ttm)2.95B
Revenue per share (ttm)39.70
Quarterly revenue growth (yoy)3.30%
Gross profit (ttm)N/A
Net income avi to common (ttm)593.4M
Diluted EPS (ttm)7.89
Quarterly earnings growth (yoy)33.00%

Balance sheet

Total cash (mrq)853.9M
Total cash per share (mrq)11.65
Total debt (mrq)309M
Total debt/equity (mrq)10.73%
Current ratio (mrq)2.88
Book value per share (mrq)39.20

Cash flow statement

Operating cash flow (ttm)776.5M
Levered free cash flow (ttm)199.04M